Feasibility, acceptability, and safety of a novel device for self-collecting capillary blood samples in clinical trials in the context of the pandemic and beyond
PLOS ONE · 29.05.2024 · 19 (5) · e0304155
DOI: 10.1371/journal.pone.0304155 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, online erschienen am 29.05.2024. Verfasst von Harika Dasari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research and Knowledge Transfer Unit on Childhood Asthma, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Blood Specimen Collection. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institute of Health Research.
Abstract (Originalsprache)
Background
Home blood self-collection devices can enable remote monitoring, but their implementation requires validation. Our objectives were to explore (i) the impact of sampling sites and topical analgesia on capillary blood volume and pain perception and (ii) the safety, acceptability, and failure of capillary self-collection among adults and children using the Tasso-SST device.
Methods
We conducted a two-phase study. The investigational phase consisted of two on-site cross-sectional studies in healthy adult participants (≥ 12 years) and children (1–17 years) with their accompanying parent. Adults received 4 capillary samplings, where puncture sites and topical analgesia were randomized in a factorial design, and a venipuncture; children (and one parent) had one capillary sampling. The two co-primary outcomes were blood volume and pain. The implementation phase was conducted in two multicentre trials in participants choosing remote visits; blood volume, collection failure, adverse events, and satisfaction were documented.
Results
In the investigational phase , 90 participants and 9 children with 7 parents were enrolled; 15 adults and 2 preschoolers participated in the implementation phase . In the adult investigational study, the device collected a median (25%, 75%) of 450 (250, 550) μl of blood with no significant difference between the puncture site, topical analgesia, and its interaction. Using topical analgesia reduced pain perception by 0.61 (95% CI: 0.97, 0.24; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Clinical Research and Knowledge Transfer Unit on Childhood Asthma, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.
- Department of Pediatrics, University of Montréal, Quebec, Canada.
- Department of Social and Preventive Medicine, School of Public Health, University of Montreal, Québec, Canada.
ORCID-Profile: Francine M Ducharme
Förderung
- Canadian Institute of Health Research
Zitieren
APA
Dasari, H., Smyrnova, A., Leng, J., & Ducharme, F. M. (2024). Feasibility, acceptability, and safety of a novel device for self-collecting capillary blood samples in clinical trials in the context of the pandemic and beyond. PLOS ONE, 19(5), e0304155. https://doi.org/10.1371/journal.pone.0304155
Vancouver
Dasari H, Smyrnova A, Leng J, Ducharme FM. Feasibility, acceptability, and safety of a novel device for self-collecting capillary blood samples in clinical trials in the context of the pandemic and beyond. PLOS ONE. 2024;19(5):e0304155. doi:10.1371/journal.pone.0304155
BibTeX
@article{Dasari2024,
author = {Dasari, Harika and Smyrnova, Anna and Leng, Jing and Ducharme, Francine M},
title = {Feasibility, acceptability, and safety of a novel device for self-collecting capillary blood samples in clinical trials in the context of the pandemic and beyond},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {5},
pages = {e0304155},
doi = {10.1371/journal.pone.0304155}
}
EUVIMED